Further re Rule 2.11d disclosure
10 Diciembre 2010 - 8:26AM
UK Regulatory
TIDMBII TIDMBGC
Disclosure under Rule 2.11d of The Takeover Code
Aberforth Partners LLP ("Aberforth") provided a non-binding letter of intent to
BTG plc regarding BTG plc's proposed acquisition of Biocompatibles
International plc ("Biocompatibles"), as referred to in the announcement of the
acquisition dated 19 November 2010. On 09 December 2010, Aberforth disposed of
40,057 shares (over which it had voting authority) in Biocompatibles, on behalf
of clients. As a result, Aberforth now intends to vote in favour of the
resolutions to be proposed at the Court Meeting and the Biocompatibles general
meeting necessary to approve the Scheme (or as the case may be, to accept the
Takeover Offer) in respect of 3,676,082 Biocompatibles shares, over which it
has voting authority.
Date: 10 December 2010
Contact: Pauline Robson, for Aberforth Partners LLP
Telephone: 0131 220 0733
END
Biocompatibles (LSE:BII)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Biocompatibles (LSE:BII)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Biocompatibles (London Stock Exchange): 0 recent articles
Más de Biocompatibles Artículos de Noticias